Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5932793 | The American Journal of Pathology | 2014 | 8 Pages |
Abstract
Penile squamous cell carcinoma (PSCC) is a rare tumor associated with high-risk human papillomavirus (HR-HPV) infection in 30% to 60% of cases. Altered expression of miRNAs has been reported in HPV-related cervical and head and neck cancers, but such data have not been available for PSCC. We analyzed a series of 59 PSCCs and 8 condylomata for presence of HPV infection, for p16INK4a, Ki-67, and p53 immunohistochemical expression, and for expression of a panel of cellular miRNAs (let-7c, miR-23b, miR-34a, miR-145, miR-146a, miR-196a, and miR-218) involved in HPV-related cancer. HR-HPV DNA (HPV16 in most cases) was detected in 17/59 (29%) PSCCs; all penile condylomata (8/8) were positive for low-risk HPV6 or HPV11. HR-HPV+ PSCCs overexpressed p16INK4a in 88% cases and p53 in 35% of cases, whereas HR-HPVâ PSCCs were positive for p16INK4a and p53 immunostaining in 9% and 44% of cases, respectively. Among the miRNAs investigated, expression of miR-218 was lower in PSCCs with HR-HPV infection and in p53â cancers. Hypermethylation of the promoter of the SLIT2 gene, which contains miR-218-1 in its intronic region, was frequently observed in PSCCs, mainly in those with low miR-218 expression. Epigenetic silencing of miR-218 is a common feature in HR-HPV+ PSCCs and in HR-HPVâ PSCCs without immunohistochemical detection of p53.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Luisa Barzon, Rocco Cappellesso, Elektra Peta, Valentina Militello, Alessandro Sinigaglia, Matteo Fassan, Francesca Simonato, Vincenza Guzzardo, Laura Ventura, Stella Blandamura, Marina Gardiman, Giorgio Palù, Ambrogio Fassina,